The role of FDG positron emission tomography in mediastinal lymph node evaluation for lung cancer

O. Eroglu, S. Ziyade, A. Toker, S. Tanju, S. Dilege, G. Kalayci (Istanbul, Turkey)

Source: Annual Congress 2006 - Early detection, diagnosis, staging and clinical features of lung cancer
Session: Early detection, diagnosis, staging and clinical features of lung cancer
Session type: Electronic Poster Discussion
Number: 800
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Eroglu, S. Ziyade, A. Toker, S. Tanju, S. Dilege, G. Kalayci (Istanbul, Turkey). The role of FDG positron emission tomography in mediastinal lymph node evaluation for lung cancer. Eur Respir J 2006; 28: Suppl. 50, 800

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The role of mediastinoscopy on staging of NSCLC patients with negative mediastinal lymph node uptake on positron emission tomography imaging
Source: Annual Congress 2008 - Congenital lung lesions and emphysema; lung cancer surgery
Year: 2008


The accuracy of positron emission thomography in mediastinal lymph node staging of non small cell lung cancer
Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Year: 2008


Mediastinal lymph node staging in nonsmall cell lung cancer: comparison of positron emission tomography and mediastinoscopy
Source: Annual Congress 2007 - Staging, diagnostic procedures and complex situations in thoracic surgery
Year: 2007


EBUS-TBNA in positron emission tomography (PET) positive mediastinal lymph nodes in previously radically treated malignancies
Source: International Congress 2016 – Endosonography: EBUS/EUS (B)
Year: 2016


Does prior mediastinal lymph node aspiration contribute to false-positive positron emission tomography–computed tomography?
Source: ERJ Open Res, 6 (4) 00103-2020; 10.1183/23120541.00103-2020
Year: 2020



Endobronchial ultrasound and PET positive mediastinal lymph nodes
Source: Annual Congress 2005 - Screening and imaging of lung cancer
Year: 2005


Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer
Source: Eur Respir J 2007; 29: 995-1002
Year: 2007



Endobronchial ultrasound and positron emission tomography positive mediastinal lymph nodes
Source: Eur Respir J 2006; 27: 276-281
Year: 2006



Endobronchial ultrasound guided biopsy (EBUS–TBNA) for staging of patients with lung cancer without mediastinal involvement at positron emission tomography-computed tomography (PET-CT)
Source: International Congress 2016 – Endosonography: EBUS/EUS (B)
Year: 2016


Assessment with STIR MR imaging and PET-CT for malignant or benign lesion in the mediastinal and hilar lymph nodes
Source: Annual Congress 2007 - Diagnosis and staging of lung cancer: existing and new techniques
Year: 2007



Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration
Source: Eur Respir J 2009; 33: 201-212
Year: 2009



The role of positron emission tomography scan in the preoperative staging of nonsmall cell lung cancer
Source: Annual Congress 2008 - Diagnostic and therapeutic problems in thoracic surgery
Year: 2008

The importance of positron emission tomography/computed tomography (PET-CT) to identify distant metastasis in non-small cell lung cancer (NSCLC)
Source: Annual Congress 2010 - Staging of lung cancer
Year: 2010


Integrated positron emission tomography-computed tomography (PET-CT) in the staging of lung cancer
Source: Annual Congress 2008 - New imaging modalities in the staging of lung cancer
Year: 2008


Prognostic value of fluorine-18 fluorodeoxyglucose (18-FDG) positron emission tomography imaging in patients with non-small cell lung carcinoma
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012

The role of positron emission tomography with 18F-2-fluoro-2-deoxy-D-glucose in respiratory oncology
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-34-0, page=245
Year: 2004

Positron emission tomography with 18F-fluoro-deoxyglucose (FDG-PET) for evaluation of indeterminate adrenal mass in patients with lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 596s
Year: 2002

Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the clinical diagnosis of lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 227s
Year: 2001

Clinicopathologic comparison of computed tomography and positron emission tomography scanning for mediastinal staging in NSCLC
Source: Annual Congress 2010 - Actual challenges in thoracic surgery
Year: 2010



False- positive and false-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in non-small-cell lung cancer
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014